Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1982 Jul 17;285(6336):174–175. doi: 10.1136/bmj.285.6336.174

Acquired inhibitor to human factor VIII associated with paraproteinaemia and subsequent development of chronic lymphatic leukaemia.

P R Kelsey, M J Leyland
PMCID: PMC1499400  PMID: 6807397

Full text

PDF
174

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axelsson U. An eleven-year follow-up on 64 subjects with M-components. Acta Med Scand. 1977;201(3):173–175. doi: 10.1111/j.0954-6820.1977.tb15676.x. [DOI] [PubMed] [Google Scholar]
  2. Glueck H. I., Hong R. A circulating anticoagulant in gamma-1A-multiple myeloma: its modification by penicillin. J Clin Invest. 1965 Nov;44(11):1866–1881. doi: 10.1172/JCI105294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Wenz B., Friedman G. Acquired factor VIII inhibitor in a patient with malignant lymphoma. Am J Med Sci. 1974 Nov;268(5):295–299. doi: 10.1097/00000441-197411000-00008. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES